目錄:MedChemExpress LLC>>信號通路>> PF-4136309 | MedChemExpress (MCE)
CAS | 1341224-83-6 | 純度 | 99.59% |
---|---|---|---|
分子量 | 568.59 | 分子式 | C??H??F?N?O? |
供貨周期 | 現(xiàn)貨 | 規(guī)格 | 10 mM * 1 mL |
貨號 | HY-13245 | 應(yīng)用領(lǐng)域 | 醫(yī)療衛(wèi)生,化工,生物產(chǎn)業(yè),制藥 |
MCE 的所有產(chǎn)品僅用作科學(xué)研究或藥證申報,我們不為任何個人用途提供產(chǎn)品和服務(wù)。
CAS No. : 1341224-83-6
MCE 國際站:PF-4136309
產(chǎn)品活性:PF-4136309 是一種高效,選擇性,可口服的 CCR2 拮抗劑,能夠抑制人,小鼠和大鼠 CCR2,IC50 值分別為 5.2 nM,17 nM 和 13 nM。
研究領(lǐng)域:GPCR/G Protein | Immunology/Inflammation
作用靶點:CCR
In Vitro: PF-4136309 is potent in human chemotaxis activity (IC50=3.9 nM) and in the whole blood assay (IC50=19 nM), with IC50 of 16 and 2.8 nM in mouse and rat chemotaxis assays. PF-4136309 is potent in inhibiting CCR2 mediated signaling events such as intracellular calcium mobilization and ERK (extracellular signal-regulated kinase) phosphorylation with IC50 values of 3.3 and 0.5 nM, respectively. In hERG patch clamp assay, PF-4136309 inhibits hERG potassium current with an IC50 of 20 μM. PF-4136309 is not a cytochrome P450 (CYP) inhibitor, with IC50 values of >30 μM against five major CYP isozymes CYP1A2, CYP2C9, CYP2C19, CYP2D6, and CYP3A4. Moreover, PF-4136309 is not a CYP inducer at concentrations up to 30 μM.
In Vivo: PF-4136309 (2 mg/kg) exhibits a moderate half-life in both species after iv administration (2.5 and 2.4 h). When administered orally, PF-4136309 (10 mg/kg) is absorbed rapidly, with peak concentration time (Tmax) at 1.2 h for rats and 0.25 h for dogs. A similar half-life is observed in both species between iv dosing and po dosing. PF-4136309 is well absorbed, with an oral bioavailability of 78% in both species.
相關(guān)產(chǎn)品:Drug Repurposing Compound Library Plus | Clinical Compound Library Plus | Bioactive Compound Library Plus | GPCR/G Protein Compound Library | Immunology/Inflammation Compound Library | Clinical Compound Library | Small Molecule Immuno-Oncology Compound Library | Drug Repurposing Compound Library | Endocrinology Compound Library | Orally Active Compound Library | Anti-Pulmonary Fibrosis Compound Library | Chemokine Compound Library | Heterocyclic Compound Library | Membrane Protein-targeted Compound Library | Membrane Receptor-targeted Compound Library | Highly Selective Inhibitors Library | Cytokine Inhibitors Library | Pirfenidone | Maraviroc | RS 504393 | Bindarit | INCB3344 | BX471 | RS102895 hydrochloride | Cenicriviroc | TAK-779 | CCR6 inhibitor 1 | Zelnecirnon | CCR6 antagonist 1 | AZ084 | ZK756326 dihydrochloride | AZD2098 | GW 766994 | R243 | 7,4'-Dihydroxyflavone | BMS-813160 | CCR7 Ligand 1 | MK-0812 Succinate | K777 | Vercirnon | DAPTA | Tivumecirnon | C-021 | CCR2 antagonist 4 hydrochloride | INCB 3284
熱門產(chǎn)品線:重組蛋白 | 化合物庫 | 天然產(chǎn)物 | 熒光染料 | PROTAC | 同位素標記物
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Dye Reagents | PROTAC | Isotope-Labeled Compounds